Phizzle
Latest round
- Series B
Last raised
- Nov 2013
Total raised
- $5.9M
Investors
- 1
About Phizzle
Founded in 2005 in San Francisco, US, Phizzle specializes in pharmaceutical data solutions. The company was co-founded by Ben Davis and Ira Shapiro.Phizzle specializes in providing cutting-edge solutions for the pharmaceutical manufacturing sector, with its flagship product, the EDGMaker platform, serving as a central hub for managing drug production data. The EDGMaker is uniquely designed to facilitate data normalization and automate instrument operations, enhancing data accessibility and operational efficiency. This software-defined architecture (SDA) enables users to manage a diverse range of scientific instruments from various vendors through a single user interface, addressing a critical need for interoperability in pharmaceutical labs. Phizzle’s client base includes pharmaceutical companies that utilize their technology for production processes, ensuring compliance with Good Manufacturing Practices (GMP) while streamlining data collection and record-keeping.Phizzle's revenue structure is primarily based on subscriptions and partnerships with pharmaceutical manufacturers who require advanced data management solutions for their scientific instruments. The company offers various pricing plans which include access to the EDGMaker platform and associated services that enhance productivity and data integrity. Transactions typically occur through direct sales to B2B clients, allowing pharmaceutical companies to integrate Phizzle's technology into their existing operations seamlessly. Clients benefit from the software’s capabilities to automate processes and ensure compliance, resulting in a cost-effective solution that can significantly improve manufacturing efficiency.Phizzle is strategically focusing on developing new features for the EDGMaker platform, with plans for a product update expected later in 2023. The company aims to expand its market presence in Asia and Latin America by 2024, seeking partnerships with local pharmaceutical firms.90 mn will be utilized to support these initiatives, enhancing product development and facilitating entry into new markets.
Who invested in Phizzle
1 investor across 2 rounds
See all investors in Phizzle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phizzle
Who invested in Phizzle?
Phizzle has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phizzle raised?
Phizzle has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Phizzle last raise money?
Phizzle's most recent round on record is a Series B, in Nov 2013.
What does Phizzle do?
Founded in 2005 in San Francisco, US, Phizzle specializes in pharmaceutical data solutions.
Where is Phizzle headquartered?
Phizzle is headquartered in San Francisco, US.
Which VCs invest in companies like Phizzle?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back marketing/advertising companies at Phizzle's stage. Their profiles are linked below.
VCs backing marketing/advertising startups at Series B
Raising like Phizzle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.